InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
0.00%
)
US TECH 100
17,007.60
(
0.87%
)
Dow Jones
37,903.29
(
0.00%
)
Brent Oil
83.68
(
0.16%
)
Bitcoin
58,531.80
(
0.50%
)
Post# of 251673
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119535
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ronpopeil post# 238000

Monday, 05/10/2021 11:53:23 AM

Monday, May 10, 2021 11:53:23 AM

Post# of 251673
ABBV acquires SOLY for $22.60 cash—a 26% premium to Friday’s closing price:

https://finance.yahoo.com/news/allergan-aesthetics-acquire-soliton-expanding-123000839.html

SOLY has a device that uses ultrasound for short-term improvement in the appearance of cellulite and to facilitate tattoo removal (in conjunction with laser treatment).

The nominal deal value is $550M.

Allergan overpaid hugely for Zeltiq’s CoolSculpting in 2017 (#msg-128649430, #msg-153884422), but today’s deal for SOLY is much less costly.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up